Sigma Planning Corp Syndax Pharmaceuticals Inc Transaction History
Sigma Planning Corp
- $3.02 Billion
- Q1 2025
A detailed history of Sigma Planning Corp transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Sigma Planning Corp holds 16,985 shares of SNDX stock, worth $163,565. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,985
Previous 17,785
4.5%
Holding current value
$163,565
Previous $235,000
11.49%
% of portfolio
0.01%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding SNDX
# of Institutions
238Shares Held
101MCall Options Held
1.36MPut Options Held
618K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$82 Million8.82% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$76.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.87MShares$46.9 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.21MShares$40.6 Million5.73% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.01MShares$38.6 Million0.12% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $545M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...